For example, CRISPR/Cas9‐mediated deletion (191 bp) of −7.5 kb upstream regions of TAL1, which is bound by the transcription factor MYB, reduced the expression of TAL1 by ~85% in human Jurkat leukemia cells (Mansour et al, 2014). This evidence concerns the gene MYB and leukemia.